Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, par value (euro)0.12 per share
-
Shares outstanding
-
22,421,536
-
Total 13F shares
-
7,856,016
-
Share change
-
-1,881,152
-
Total reported value
-
$26,624,069
-
Put/Call ratio
-
51%
-
Price per share
-
$3.41
-
Number of holders
-
74
-
Value change
-
-$5,834,095
-
Number of buys
-
30
-
Number of sells
-
39
Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) as of Q4 2024
As of 31 Dec 2024,
CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,856,016 shares.
The largest 10 holders included
MILLENNIUM MANAGEMENT LLC, BlackRock, Inc., UBS Group AG, Alyeska Investment Group, L.P., Point72 Asset Management, L.P., GOLDMAN SACHS GROUP INC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, GEODE CAPITAL MANAGEMENT, LLC, and Swiss National Bank.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.